Stylus Medicine
5 known investors
Find your way into Stylus Medicine
2,669 people in our graph share verified history with the Stylus Medicine team — schools, employers, funds. One of them is your warm intro.
Aydin Senkutunlockedknows Michael C. Bassik, Ph.D. · together at Notion (overlapped)
×6knows the team · via Stanford University
knows the team · via Notion
×3knows the team · via Broad Institute of MIT and Harvard
knows the team · via Harvard University
Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.
Founders & leadership
MC
Michael C. Bassik, Ph.D.inScientific FounderMichael Bassik is a founder of Stylus Medicine, which develops in vivo genetic medicines using engineered recombinases. He holds a Ph.D. and has background in genetic engineering and therapeutic development.
EN
Emile Nuwaysir, Ph.D.inChairman & Chief Executive Officer
JF
Jason Fontenot, Ph.D.Chief Scientific Officer
Investors · 5
Founder mafia
2 people who came through Stylus Medicine went on to found or lead other companies.
Competitors · 3
by search overlap
Talus Bio19 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Trisaluslifesci15 shared keywordsTriSalus develops a therapeutic platform combining its Pressure-Enabled Drug Delivery (PEDD) method with immune-activating therapies to overcome intratumoral pressure and immunosuppression that limit treatment of liver and pancreatic tumors. The platform is designed to be used alongside systemic immunotherapies such as checkpoint inhibitors for cancer patients.
Bioworld14 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Stylus Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Stylus Medicine do?
- Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.
- Who founded Stylus Medicine?
- Stylus Medicine was founded by Michael C. Bassik, Ph.D..
- Who are Stylus Medicine's investors?
- Stylus Medicine's investors include Brainstorm Ventures, Khosla Ventures, Neva Sgr., RA Capital, Tachyon Ventures.